Inhibition of BET bromodomain, epigenetic regulator, as an effective therapeutic approach for gastric cancer

被引：0
|
作者：
Kang, Sun Kyoung
Kim, Tae Soo
Kwon, Woo Sun
Roh, Jae Kyung
Lim, Ho-Yeong
Chun, Hyun Cheol
Rha, Sun Young
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5069
引用
收藏
页数：2
相关论文
共 50 条
  • [21] BET bromodomain inhibition as a therapeutic strategy to target N-Myc in neuroblastoma
    Shahbazi, J.
    Lock, R.
    Liu, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S356 - S356
  • [22] Inhibition of bromodomain and extraterminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence
    Chaidos, Aristeidis
    Caputo, Valentina
    Karadimitris, Anastasios
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (03) : 128 - 141
  • [23] Inhibition of epigenetic regulator-Bromodomain 4 halts the onset of diabetic retinopathy
    Taylor, Patricia R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [24] BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer
    Coleman, Daniel J.
    Gao, Lina
    King, Carly J.
    Schwartzman, Jacob
    Urrutia, Joshua
    Sehrawat, Archana
    Tayou, Junior
    Balter, Ariel
    Burchard, Julja
    Chiotti, Kami E.
    Derrick, Daniel S.
    Sun, Duanchen
    Xia, Zheng
    Heiser, Laura M.
    Alumkal, Joshi J.
    ONCOGENE, 2019, 38 (28) : 5658 - 5669
  • [25] BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer
    Daniel J. Coleman
    Lina Gao
    Carly J. King
    Jacob Schwartzman
    Joshua Urrutia
    Archana Sehrawat
    Junior Tayou
    Ariel Balter
    Julja Burchard
    Kami E. Chiotti
    Daniel S. Derrick
    Duanchen Sun
    Zheng Xia
    Laura M. Heiser
    Joshi J. Alumkal
    Oncogene, 2019, 38 : 5658 - 5669
  • [26] BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
    Karakashev, Sergey
    Zhu, Hengrui
    Yokoyama, Yuhki
    Zhao, Bo
    Fatkhutdinov, Nail
    Kossenkov, Andrew V.
    Wilson, Andrew J.
    Simpkins, Fiona
    Speicher, David
    Khabele, Dineo
    Bitler, Benjamin G.
    Zhang, Rugang
    CELL REPORTS, 2017, 21 (12): : 3398 - 3405
  • [27] Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer
    Wahi, Abhishek
    Manchanda, Namish
    Jain, Priti
    Jadhav, Hemant R.
    BIOORGANIC CHEMISTRY, 2023, 140
  • [28] Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
    Kandela, Irawati
    Jin, Hyun Yong
    Owen, Katherine
    ELIFE, 2015, 4
  • [29] Inhibition of epigenetic regulator menin is a novel therapeutic approach for high-risk neuroblastoma
    Chilamakuri, Rameswari
    Agarwal, Saurabh
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
    Aird, Fraser
    Kandela, Irawati
    Mantis, Christine
    ELIFE, 2017, 6
12345